As on date of publishing, this report will capture the impact assessment of COVID-19 on this market and the same will be considered in our market forecast model. Clients purchasing this report between April and June 2020 will be getting a ‘free’ updated market data excel sheet between July and September 2020 accounting for the impact of COVID-19 on the market in the current year 2020 and forecast.

India clindamycin HCL market is expected to grow at a steady rate during the forecast period. The India clindamycin HCL market is driven by the widespread use of the medication in treatment of serious infections caused by anaerobic bacteria’s such as intrabdominal infections, skin infections, among others. Additionally, clindamycin is used in combination with other antibacterial agents against a wide range of gram negative bacteria. This in turn is expected to increase the demand for clindamycin thereby fueling the market growth through FY2026. Furthermore, clindamycin is used in patients allergic to penicillin. This in turn is expected to positively influence the market growth over the next few years.

The India clindamycin HCL market is segmented based on route of administration, source, form, distribution channel, application, company and region. Based on route of administration, the market can be split into oral and intravenous. The oral route is expected to dominate the market owing to the associated benefits such as self-administration, patient compliance, cost effectiveness, among others. Additionally, after consumption through oral route the absorption takes along the whole length of GI tract.

The major players operating in the India clindamycin HCL market are Midas Pharma India Private Limited, Baxter Pharmaceuticals India Pvt. Ltd., Fresenius Kabi India Private Limited, Merck India Pvt. Ltd., Sun Pharmaceuticals Industries Ltd., Cadila Pharmaceuticals Ltd., Glenmark Pharmaceuticals Limited, Abbott India Limited, GlaxoSmithKline Pharmaceuticals Ltd., Viraj Pharmaceuticals Pvt. Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. Other competitive Go-To-Market strategies include mergers & acquisitions, portfolio enhancement and new product developments.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India clindamycin HCL market from FY2016 to FY2019.
  • To estimate and forecast the market size of India clindamycin HCL market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India clindamycin HCL market based on route of administration, source, form, distribution channel, application, company and regional distribution.
  • To identify dominant region or segment in the India clindamycin HCL market.
  • To identify drivers and challenges for India clindamycin HCL market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India clindamycin HCL market.
  • To identify and analyze the profile of leading players operating in India clindamycin HCL market.
  • To identify key sustainable strategies adopted by market players in India clindamycin HCL market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India clindamycin HCL market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Clindamycin HCL manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to clindamycin HCL

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India clindamycin HCL market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Clindamycin HCL Market, By Route of Administration:
    • Oral
    • Intravenous
  • India Clindamycin HCL Market, By Source:
    • In-House
    • Contract Manufacturing Organizations
  • India Clindamycin HCL Market, By Form:
    • Tablet
    • Capsule
    • Injection
    • Others
  • India Clindamycin HCL Market, By Distribution Channel:
    • Online
    • Offline
  • India Clindamycin HCL Market, By Application:
    • Bacterial Infections
    • Skin and Soft Tissue Infections
    • Respiratory Tract Infections
    • Lung Infections
    • Others
  • India Clindamycin HCL Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India clindamycin HCL market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India Clindamycin HCL market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at  

In case you don’t find what you are looking for, please get in touch with our custom research team at

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Clindamycin HCL Market

4.    Executive Summary

5.    Manufacturing Clindamycin HCL

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Clindamycin HCL

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Clindamycin HCL Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Route of Administration (Oral v/s Intravenous)

7.2.2.     By Form (Tablet, Capsule, Injection, Others)

7.2.3.     By Application (Bacterial Infections, Skin and Soft Tissue Infections, Respiratory Tract Infections, Lung Infections, Others)

7.2.4.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.5.     By Distribution Channel (Online v/s Offline)

7.2.6.     By Region (North, East, South, West)

7.2.7.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Midas Pharma India Private Limited      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Baxter Pharmaceuticals India Pvt. Ltd.

14.1.3.  Fresenius Kabi India Private Limited

14.1.4.  Merck India Pvt. Ltd.

14.1.5.  Sun Pharmaceuticals Industries Ltd.

14.1.6.  Cadila Pharmaceuticals Ltd.

14.1.7.  Glenmark Pharmaceuticals Limited

14.1.8.  Abbott India Limited

14.1.9.  GlaxoSmithKline Pharmaceuticals Ltd.

14.1.10.                Viraj Pharmaceuticals Pvt. Ltd.

15.  Strategic Recommendations

16.  About Us & Disclaimer 

In case you don’t find what you are looking for, please get in touch with our custom research team at